Search SciPol

Brought to you by
August 16, 2017

FDA approves emergency use declaration for multiplex Zika test

  • Government
  • Agency
  • Industry
  • Neuroscience

UPI – The U.S. Food and Drug Administration has issued an Emergency Use Authorization for the first multiplex test for the Zika virus and three other viruses.

The FDA made the authorization for CII-ArboViroPlex rRT-PCR Test developed by the Center for Infection and Immunity, or CII, at Columbia University's Mailman School of Medicine Monday.

"The ArboViroPlex Test provides an easy and efficient means to simultaneously detect Zika and three other mosquito-borne viral infections that may present with similar clinical features," Nischay Mishra, the lead project scientist and associate research scientist at CII, said in a press release.

The CII-ArboViroPlex rRT-PCR Test is the first multiplex test that can detect the Zika virus and all serotypes of dengue virus, chikungunya virus and West Nile virus simultaneously.

Read more at UPI.

Image Citation